SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rajshekhar Chakraborty, Bipin N. Savani, Mark Litzow, Mohamad Mohty, Shahrukh Hashmi, A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties, Cancer, 2015, 121, 11
  2. 2
    Jacqueline Casillas, Kevin C. Oeffinger, Melissa M. Hudson, Mark L. Greenberg, Mark W. Yeazel, Kirsten K. Ness, Tara O. Henderson, Leslie L. Robison, Gregory T. Armstrong, Qi Liu, Wendy Leisenring, Yutaka Yasui, Paul C. Nathan, Identifying Predictors of Longitudinal Decline in the Level of Medical Care Received by Adult Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study, Health Services Research, 2015, 50, 3
  3. 3
    Hannah K. Weir, Trevor D. Thompson, Ashwini Soman, Bjørn Møller, Steven Leadbetter, The past, present, and future of cancer incidence in the United States: 1975 through 2020, Cancer, 2015, 121, 11
  4. 4
    Carol M. Lewis, Gregory M. Chronowski, Wenli Dong, G. Brandon Gunn, David I. Rosenthal, Randal S. Weber, Analysis of Charges Associated with Definitive Nonsurgical Therapy for Early-Stage Lateralized Tonsil Cancer, Annals of Surgical Oncology, 2014,

    CrossRef

  5. 5
    Yuko Kamijo, Motoki Ichikawa, Cost information of chemotherapy for cervical and endometrial cancer in Japan, Japan Journal of Nursing Science, 2014, 11, 3
  6. 6
    Nicolas Batty, Joseph Shatzel, Samuel Wiles, Mathew Kabalan, Rohit Sharma, Jonathan Pang, David Yi, Iris Alatovic, Sana Saif, Deepika Narasimha, Joseph LaPenna, Anthony Troitino, Kristopher Attwood, Michael Weinstein, Eric Murawski, Mathew Valerio, Yong Yin, Meir Wetzler, Deficiencies of methods applied in cost effectiveness analysis of hematological malignancies, Journal of Cancer Policy, 2014, 2, 2, 40

    CrossRef

  7. 7
    Diarmuid Coughlan, Susan T. Yeh, Ciaran O’Neill, Kevin D. Frick, Evaluating Direct Medical Expenditures Estimation Methods of Adults Using the Medical Expenditure Panel Survey: An Example Focusing on Head and Neck Cancer, Value in Health, 2014, 17, 1, 90

    CrossRef

  8. 8
    Julieta F Scalo, Karen L Rascati, Trends and issues in oncology costs, Expert Review of Pharmacoeconomics & Outcomes Research, 2014, 14, 1, 35

    CrossRef

  9. 9
    Madhu Rao, Thomas W Concannon, Ramon Iovin, Winifred W Yu, Jeffrey A Chan, Georgios Lypas, Teruhiko Terasawa, James M Gaylor, Lina Kong, Andrew C Rausch, Joseph Lau, Georgios D Kitsios, Identification of topics for comparative effectiveness systematic reviews in the field of cancer imaging, Journal of Comparative Effectiveness Research, 2013, 2, 5, 483

    CrossRef

  10. 10
    Guixiang Zhao, Chaoyang Li, Jun Li, Lina S. Balluz, Physical activity, psychological distress, and receipt of mental healthcare services among cancer survivors, Journal of Cancer Survivorship, 2013, 7, 1, 131

    CrossRef

  11. 11
    Binbing Yu, Predicting county-level cancer incidence rates and counts in the USA, Statistics in Medicine, 2013, 32, 22
  12. 12
    R.M. WOODWARD, J. MENZIN, P.J. NEUMANN, Quality-adjusted life years in cancer: pros, cons, and alternatives, European Journal of Cancer Care, 2013, 22, 1
  13. 13
    Florence K. Tangka, Justin G. Trogdon, Donatus U. Ekwueme, Gery P. Guy, Isaac Nwaise, Diane Orenstein, State-level cancer treatment costs, Cancer, 2013, 119, 12
  14. 14
    L. K. Hicks, H. Bering, K. R. Carson, J. Kleinerman, V. Kukreti, A. Ma, B. U. Mueller, S. H. O'Brien, M. Pasquini, R. Sarode, L. Solberg, A. E. Haynes, M. A. Crowther, The ASH Choosing Wisely(R) campaign: five hematologic tests and treatments to question, Hematology, 2013, 2013, 1, 9

    CrossRef

  15. 15
    L. K. Hicks, H. Bering, K. R. Carson, J. Kleinerman, V. Kukreti, A. Ma, B. U. Mueller, S. H. O'Brien, M. Pasquini, R. Sarode, L. Solberg, A. E. Haynes, M. A. Crowther, The ASH Choosing Wisely(R) campaign: five hematologic tests and treatments to question, Blood, 2013, 122, 24, 3879

    CrossRef

  16. 16
    Adekunle O. Oguntayo, Marliya Zayyan, Mattew Akpar, Abimbola O. D. Kolawole, Sunday A. Adewuyi, The burden of gynecological cancer management in Northern Nigeria, Open Journal of Obstetrics and Gynecology, 2013, 03, 08, 634

    CrossRef

  17. 17
    Stefano Menegatti, Amith D Naik, Ruben G Carbonell, The hidden potential of small synthetic molecules and peptides as affinity ligands for bioseparations, Pharmaceutical Bioprocessing, 2013, 1, 5, 467

    CrossRef

  18. 18
    Mo Yang, Dhaval S Patel, Waqas Tufail, Amalia M Issa, The quality of economic studies of cancer pharmacogenomics: a quantitative appraisal of the evidence, Expert Review of Pharmacoeconomics & Outcomes Research, 2013, 13, 5, 597

    CrossRef

  19. 19
    C. Daniel Mullins, Fei-Yuan Hsiao, Eberechukwu Onukwugha, Naimish B. Pandya, Nader Hanna, Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients, Cancer, 2012, 118, 12
  20. 20
    Caitriona B. O'Neill, Coral L. Atoria, Eileen M. O'Reilly, Jennifer LaFemina, Martin C. Henman, Elena B. Elkin, Costs and trends in pancreatic cancer treatment, Cancer, 2012, 118, 20
  21. 21
    Shinichi Tanihara, Etsuji Okamoto, Hiroshi Une, Estimating medical expenditures spent on rule-out diagnoses in Japan, Journal of Evaluation in Clinical Practice, 2012, 18, 2
  22. 22
    Gery P. Guy, Donatus U. Ekwueme, Florence K. Tangka, Lisa C. Richardson, Melanoma Treatment Costs, American Journal of Preventive Medicine, 2012, 43, 5, 537

    CrossRef

  23. 23
    Michelle Y. Martin, Sara Sanders, Joan M. Griffin, Robert A. Oster, Christine Ritchie, Sean M. Phelan, Audie A. Atienza, Katherine Kahn, Michelle van Ryn, Racial Variation in the Cancer Caregiving Experience, Cancer Nursing, 2012, 35, 4, 249

    CrossRef

  24. 24
    Jed J Jacobson, Joel B Epstein, Frederick C Eichmiller, Teresa B Gibson, Ginger S Carls, Emily Vogtmann, Shaohung Wang, Barbara Murphy, The cost burden of oral, oral pharyngeal, and salivary gland cancers in three groups: commercial insurance, medicare, and medicaid, Head & Neck Oncology, 2012, 4, 1, 15

    CrossRef

  25. 25
    K. Robin Yabroff, Emily Dowling, Juan Rodriguez, Donatus U. Ekwueme, Helen Meissner, Anita Soni, Catherine Lerro, Gordon Willis, Laura P. Forsythe, Laurel Borowski, Katherine S. Virgo, The Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement, Journal of Cancer Survivorship, 2012, 6, 4, 407

    CrossRef

  26. 26
    Kenneth E. Thorpe, Meredith Philyaw, The Medicalization of Chronic Disease and Costs, Annual Review of Public Health, 2012, 33, 1, 409

    CrossRef

  27. 27
    Corinna Sorenson, Valuing end-of-life care in the United States: the case of new cancer drugs, Health Economics, Policy and Law, 2012, 7, 04, 411

    CrossRef

  28. 28
    Richard Sullivan, Jeffrey Peppercorn, Karol Sikora, John Zalcberg, Neal J Meropol, Eitan Amir, David Khayat, Peter Boyle, Philippe Autier, Ian F Tannock, Tito Fojo, Jim Siderov, Steve Williamson, Silvia Camporesi, J Gordon McVie, Arnie D Purushotham, Peter Naredi, Alexander Eggermont, Murray F Brennan, Michael L Steinberg, Mark De Ridder, Susan A McCloskey, Dirk Verellen, Terence Roberts, Guy Storme, Rodney J Hicks, Peter J Ell, Bradford R Hirsch, David P Carbone, Kevin A Schulman, Paul Catchpole, David Taylor, Jan Geissler, Nancy G Brinker, David Meltzer, David Kerr, Matti Aapro, Delivering affordable cancer care in high-income countries, The Lancet Oncology, 2011, 12, 10, 933

    CrossRef

  29. 29
    Pamela Farley Short, John R. Moran, Rajeshwari Punekar, Medical expenditures of adult cancer survivors aged <65 years in the United States, Cancer, 2011, 117, 12
  30. 30
    A. B. Mariotto, K. Robin Yabroff, Y. Shao, E. J. Feuer, M. L. Brown, Projections of the Cost of Cancer Care in the United States: 2010-2020, JNCI Journal of the National Cancer Institute, 2011, 103, 2, 117

    CrossRef

  31. 31
    Michael B. Fenn, Petros Xanthopoulos, Georgios Pyrgiotakis, Stephen R. Grobmyer, Panos M. Pardalos, Larry L. Hench, Raman Spectroscopy for Clinical Oncology, Advances in Optical Technologies, 2011, 2011, 1

    CrossRef

  32. 32
    John B. Kisiel, David A. Ahlquist, Stool DNA Screening for Colorectal Cancer, Journal of Clinical Gastroenterology, 2011, 45, 4, 301

    CrossRef

  33. 33
    Anthony Chukwura Mgbakor, Anthony O. Ogbonna, CAN LIFESTYLE MODIFICATION LOWER THE RISK OF PROSTATE CANCER?, BJU International, 2010, 106, 10
  34. 34
    A. Langer, Kosteneffektivität diagnostischer Verfahren, Der Onkologe, 2010, 16, 10, 992

    CrossRef

  35. 35
    Joshua Cohen, William Looney, What is the value of oncology medicines?, Nature Biotechnology, 2010, 28, 11, 1160

    CrossRef